Rchr
J-GLOBAL ID:200901043397093190   Update date: Jul. 31, 2023

Osafune Kenji

オサフネ ケンジ | Osafune Kenji
Affiliation and department:
Homepage URL  (2): https://www.cira.kyoto-u.ac.jp/j/research/osafune_summary.htmlhttp://www.osafune.icems.kyoto-u.ac.jp/
Research field  (1): Nephrology
Research keywords  (6): 再生 ,  腎臓 ,  iPS細胞 ,  Regeneration ,  Kidney ,  iPS cell
Research theme for competitive and other funds  (2):
  • 2008 - 2012 ヒトiPS細胞を用いた腎臓再生医療の開発
  • 2008 - 2012 Development of regenerative medicine for kidney disease with iPS cell
Papers (87):
  • Kyosuke Mukae, Hisanori Takenobu, Yuki Endo, Masayuki Haruta, Tianyuan Shi, Shunpei Satoh, Miki Ohira, Michinori Funato, Junya Toguchida, Kenji Osafune, et al. Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell-derived neural crest cells. Cancer Science. 2023. 114. 5. 1898-1911
  • Hiraku Tsujimoto, Naoko Katagiri, Yoshihiro Ijiri, Ben Sasaki, Yoshifumi Kobayashi, Akira Mima, Makoto Ryosaka, Kenichiro Furuyama, Yoshiya Kawaguchi, Kenji Osafune. In vitro methods to ensure absence of residual undifferentiated human induced pluripotent stem cells intermingled in induced nephron progenitor cells. PLOS ONE. 2022. 17. 11. e0275600-e0275600
  • Kazuyoshi Yamamoto, Masahiro Okabe, Keiko Tanaka, Takashi Yokoo, Ira Pastan, Toshikazu Araoka, Kenji Osafune, Tomohiro Udagawa, Masahiro Koizumi, Taiji Matsusaka. Podocytes are lost from glomeruli before completing apoptosis. American Journal of Physiology-Renal Physiology. 2022. 323. 5. F515-F526
  • Yuta Tsujisaka, Takeshi Hatani, Chikako Okubo, Ryo Ito, Azuma Kimura, Megumi Narita, Kazuhisa Chonabayashi, Shunsuke Funakoshi, Antonio Lucena-Cacace, Taro Toyoda, et al. Purification of human iPSC-derived cells at large scale using microRNA switch and magnetic-activated cell sorting. Stem cell reports. 2022. 17. 7. 1772-1785
  • Makoto Ryosaka, Shin-Ichi Mae, Kenji Osafune. Protocol for the generation and expansion of human iPS cell-derived ureteric bud organoids. STAR Protocols. 2022. 3. 3. 101484-101484
more...
MISC (218):
  • 清水達也, 山縣邦弘, 長船健二. 腎オルガノイドを用いた多発性嚢胞腎モデル解析. 腎臓内科 (科学評論社). 2023. 17. 6. 642-649
  • 長船健二. 腎オルガノイドを用いた研究展望. 腎臓内科 (科学評論社). 2023. 17. 6. 627-633
  • 河野 有香, 小林 恭, 長船健二. 「腎臓オルガノイド」. Medical Science Digest (ニューサイエンス社). 2023. 49. 5
  • 大槻 健弥, 長船 健二. iPS細胞. 「腎と透析」(東京医学社). 2023. 94. 3. 359-362
  • 安田勝太郎, 長船健二. 第3章応用編、第2節医療応用、iPS細胞. ゲノム編集技術~実験上のポイント/産業利用に向けた研究開発動向と安全性周知. 2023. 127-138
more...
Books (1):
  • もっとよくわかる!幹細胞と再生医療
    羊土社 2014
Lectures and oral presentations  (428):
  • 「iPS細胞による1型糖尿病根治」
    (日本IDDMネットワーク サイエンスフォーラム in 大阪)
  • 臓器再生のフロンティア「iPS 細胞を用いた腎、膵、肝疾患に対する再生医療と新規治療薬の開発」
    (第 96 回日本内分泌学会学術総会特別シンポジウム3 2023)
  • “Liver Regeneration Using iPSC in Liver Cirrhosis”
    (The Liver Week 2023 2023)
  • iPSC technology-based regenerative medicine”
    (2023)
  • “iPSC-based regenerative therapies for kidney diseases and diabetes”
    (A*CGT Symposium 2023 2023)
more...
Work history (10):
  • 2022/04 - 現在 Center for iPS Cell Research and Application, Kyoto University Department of Cell Growth and Differentiation Department Head
  • 2014/10 - 現在 Center for iPS Cell Research and Application, Kyoto University Professor
  • 2010/04 - 2014/09 Center for iPS Cell Research and Application, Kyoto University Associate Professor
  • 2008/06 - 2010/03 Japan Science and Technology Agency PRESTO Research Fellow
  • 2008/06 - 2010/03 Center for iPS Cell Research and Application, Institute for Integrated Cell-Material Sciences, Kyoto University Lecturer
Show all
Association Membership(s) (7):
International Society of Differentiation ,  International Society for Stem Cell Research ,  American Society of Nephrology ,  Japan Diabetes Society ,  Japanese Society for Regenerative Medicine ,  Japanese Society for Dialysis Therapy ,  Japanese Society of Nephrology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page